NEET Zoology · Biotechnology and its Applications
Transgenic Animals and Ethical Issues
What transgenic animals are and the five reasons they are made, how India regulates GM research through GEAC, what biopiracy means, and the organism or method behind each application in the chapter.
Why this matters
Four NEET questions, all from 2024 or later. The human protein α-1-antitrypsin, used for emphysema, was asked twice (NEET 2024 and NEET 2026). GEAC and biopiracy came up in Re-NEET 2024, and two match-the-columns questions in 2024 pulled the whole chapter together: insulin with E. coli, GM cotton with Bacillus thuringiensis, ADA deficiency with gene therapy, ELISA with antigen-antibody interaction.
Concept 1 of 3: Transgenic animals and why they are made
Definition
Transgenic animals, as NCERT gives them:
- Animals whose DNA has been manipulated to possess and express an extra (foreign) gene are transgenic animals.
- Transgenic rats, rabbits, pigs, sheep, cows and fish have been produced, but over 95 per cent of all existing transgenic animals are mice.
- (i) Normal physiology and development: to study how genes are regulated and how they affect normal body functions and development, for example the study of insulin-like growth factor.
- (ii) Study of disease: as models for human diseases such as cancer, cystic fibrosis, rheumatoid arthritis and Alzheimer's.
- (iii) Biological products: transgenic animals that make useful products. The human protein α-1-antitrypsin is used to treat emphysema. Similar attempts are being made for phenylketonuria (PKU) and cystic fibrosis. In 1997 the first transgenic cow, Rosie, produced human protein-enriched milk (2.4 grams per litre). The milk contained human alpha-lactalbumin and was nutritionally more balanced for human babies than natural cow milk.
- (iv) Vaccine safety: transgenic mice are used to test the safety of vaccines before use on humans, for example the polio vaccine.
- (v) Chemical safety testing: animals made more sensitive to toxic substances than non-transgenic animals are used for toxicity testing.
| Reason | NCERT example |
|---|---|
| Normal physiology and development | Insulin-like growth factor |
| Study of disease | Models for cancer, cystic fibrosis, rheumatoid arthritis, Alzheimer's |
| Biological products | α-1-antitrypsin for emphysema; attempts for PKU and cystic fibrosis |
| Biological products | Rosie (1997): milk with human alpha-lactalbumin, 2.4 g per litre |
| Vaccine safety | Transgenic mice test the polio vaccine |
| Chemical safety testing | Animals more sensitive to toxic substances |
Practise this conceptself-check · 5 quick reps
The same idea in a real exam question:
Example 1 · Biotechnology and its Applications · Transgenic Animals and Ethical Issues
Mice, not cattle
Emphysema is the α-1-antitrypsin disease
Rosie gave a protein, not a drug
Concept 2 of 3: GEAC, patents and biopiracy
Definition
Ethical issues, as NCERT gives them:
- The Indian Government has set up organisations such as GEAC (Genetic Engineering Approval Committee), which make decisions on the validity of GM research and the safety of introducing GM organisms for public services.
- In 1997 an American company got patent rights on Basmati rice through the US Patent and Trademark Office. The "new" variety had actually been derived from Indian farmers' varieties: Indian Basmati was crossed with semi-dwarf varieties and claimed as an invention.
- There have been attempts to patent uses, products and processes based on Indian traditional herbal medicines, for example turmeric and neem.
- India alone has an estimated 200,000 varieties of rice, and 27 documented varieties of Basmati are grown in India.
- Biopiracy is the use of bio-resources by multinational companies and other organisations without proper authorisation from the countries and people concerned, without compensatory payment.
- The developing and underdeveloped world is rich in biodiversity and traditional knowledge; the industrialised nations are rich in finances and technology but poor in biodiversity.
- The Indian Parliament has cleared the second amendment of the Indian Patents Bill, which takes such issues into account.
| Term or case | What NCERT says |
|---|---|
| GEAC | Genetic Engineering Approval Committee: decides the validity of GM research and the safety of GM organisms for public services |
| Biopiracy | Use of bio-resources by multinational companies and other organisations without authorisation or compensatory payment |
| Basmati patent (1997) | An American company patented a Basmati derived from Indian farmers' varieties crossed with semi-dwarf varieties |
| Herbal medicines | Attempts to patent turmeric and neem based uses, products and processes |
| Rice diversity in India | About 200,000 varieties of rice; 27 documented varieties of Basmati |
| Indian Patents Bill | Second amendment cleared by Parliament to address these issues |
Practise this conceptself-check · 4 quick reps
The same idea in a real exam question:
Example 2 · Biotechnology and its Applications · Transgenic Animals and Ethical Issues
Biopiracy is not done by native people
GEAC judges GM research
Concept 3 of 3: One organism or method for each application
Definition
The pairings NEET matches:
- Genetically engineered human insulin: made in E. coli.
- GM (Bt) cotton: gene from Bacillus thuringiensis.
- ADA deficiency: treated by gene therapy, enzyme replacement therapy or bone marrow transplantation.
- ELISA: antigen-antibody interaction.
- PCR: amplification of nucleic acid.
- α-1-antitrypsin: emphysema.
- cryIAb: corn borer; cryIAc and cryIIAb: cotton bollworms.
- RNAi in tobacco: against the nematode Meloidogyne incognita, with genes carried by Agrobacterium.
- Golden rice: vitamin A.
| Application | Paired with |
|---|---|
| Genetically engineered human insulin | E. coli |
| GM cotton | Bacillus thuringiensis |
| ADA deficiency | Gene therapy (also enzyme replacement therapy) |
| ELISA | Antigen-antibody interaction |
| α-1-antitrypsin | EmphysemaQ NEET 2024: α-1-antitrypsin with emphysema, cry IAb with corn borer, cry IAc with cotton bollworm, enzyme replacement therapy with ADA deficiency. |
| cryIAb | Corn borer |
| cryIAc | Cotton bollworm |
| RNAi tobacco | Meloidogyne incognita |
| Golden rice | Vitamin A |
Practise this conceptself-check · 3 quick reps
The same idea in a real exam question:
Example 3 · Biotechnology and its Applications · Transgenic Animals and Ethical Issues
| List-I | List-II | |
|---|---|---|
| A. Genetically engineered Human Insulin | I. | Gene therapy |
| B. GM Cotton | II. | E. coli |
| C. ADA Deficiency | III. | Antigen-antibody interaction |
| D. ELISA | IV. | Bacillus thuringiensis |
E. coli for insulin, Bacillus for cotton
ADA deficiency has more than one treatment
Summary — formulas & gotchas at a glance
A revision cheat-sheet for the formulas and gotchas above. Click any concept name to jump back to its full explanation.
Reference tables (3)
Transgenic animals and why they are made6 rows
| Reason | NCERT example |
|---|---|
| Normal physiology and development | Insulin-like growth factor |
| Study of disease | Models for cancer, cystic fibrosis, rheumatoid arthritis, Alzheimer's |
| Biological products | α-1-antitrypsin for emphysema; attempts for PKU and cystic fibrosis |
| Biological products | Rosie (1997): milk with human alpha-lactalbumin, 2.4 g per litre |
| Vaccine safety | Transgenic mice test the polio vaccine |
| Chemical safety testing | Animals more sensitive to toxic substances |
GEAC, patents and biopiracy6 rows
| Term or case | What NCERT says |
|---|---|
| GEAC | Genetic Engineering Approval Committee: decides the validity of GM research and the safety of GM organisms for public services |
| Biopiracy | Use of bio-resources by multinational companies and other organisations without authorisation or compensatory payment |
| Basmati patent (1997) | An American company patented a Basmati derived from Indian farmers' varieties crossed with semi-dwarf varieties |
| Herbal medicines | Attempts to patent turmeric and neem based uses, products and processes |
| Rice diversity in India | About 200,000 varieties of rice; 27 documented varieties of Basmati |
| Indian Patents Bill | Second amendment cleared by Parliament to address these issues |
One organism or method for each application9 rows
| Application | Paired with |
|---|---|
| Genetically engineered human insulin | E. coli |
| GM cotton | Bacillus thuringiensis |
| ADA deficiency | Gene therapy (also enzyme replacement therapy) |
| ELISA | Antigen-antibody interaction |
| α-1-antitrypsin | EmphysemaQ NEET 2024: α-1-antitrypsin with emphysema, cry IAb with corn borer, cry IAc with cotton bollworm, enzyme replacement therapy with ADA deficiency. |
| cryIAb | Corn borer |
| cryIAc | Cotton bollworm |
| RNAi tobacco | Meloidogyne incognita |
| Golden rice | Vitamin A |
Watch out for (7)
- Mice, not cattle→ Transgenic animals and why they are made
- Emphysema is the α-1-antitrypsin disease→ Transgenic animals and why they are made
- Rosie gave a protein, not a drug→ Transgenic animals and why they are made
- Biopiracy is not done by native people→ GEAC, patents and biopiracy
- GEAC judges GM research→ GEAC, patents and biopiracy
- E. coli for insulin, Bacillus for cotton→ One organism or method for each application
- ADA deficiency has more than one treatment→ One organism or method for each application
Test yourself on a real paper
Sit a past NEET paper, timed and marked the way the exam marks it. You see your score and every answer the moment you finish. Free to start.